HIGHLIGHTS
- who: David Staskin et al. from the Tufts University School of Medicine, Boston, MA, USA have published the article: Vibegron for the Treatment of Patients with Dry and Wet Overactive Bladder: A Subgroup Analysis from the EMPOWUR Trial, in the Journal: International Journal of Clinical Practice of 13/04/2022
- how: The EMPOWUR trial was conducted in compliance with the International Council for Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use Good Clinical Practice.
SUMMARY
Among women, the overall prevalence of OAB dry and OAB wet is similar . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.